To visit the old Ventura website, click here.
Ventura Wealth Clients Login here
Refer and earnSupport
logosearch
Create Account
hamburger
home
breadcrumbStocks
breadcrumbGlenmark Pharmaceuticals Ltd Share Price

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

₹1,911.002 days ago
₹1,947.802 days ago
arrow

LOWER/UPPER CIRCUITS

₹1,743.30
₹2,130.50
arrow
Glenmark Pharmaceuticals Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 6.18%, in the last year to ₹13,435.46 Cr. Its sector's average revenue growth for the last fiscal year was 10.5%.
noteAnnual Net Profit,rose 169.73% in the last year to ₹1,047.1 Cr. Its sector's average net profit growth for the last fiscal year was 37.22%.
noteQuarterly Revenue,rose 0.62% YoY to ₹3,290.88 Cr. Its sector's average revenue growth YoY for the quarter was 9.69%.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 8.17%
Net profit growth 5Y CAGR : %

STOCK RETURNS

info
Versus Nifty 50
1 w
+0.50%
vs
-1.48%
1 mth
-9.03%
vs
+0.13%
3 mth
+41.36%
vs
-0.16%
6 mth
+52.52%
vs
+11.69%
1 yr
+14.25%
vs
-1.36%
3 yr
+416.54%
vs
+40.74%
5 yr
+294.92%
vs
+112.16%
Glenmark Pharmaceuticals Ltd Top mutual funds holding
arrow
right
Bandhan Small Cap Fund-Reg(G)
3Y Return+28.4%
NAV₹45.06
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)
3Y Return+28.2%
NAV₹39.63
left

Similar stocks

Glenmark Pharmaceuticals Limited is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Specialty Business: Drug Discovery: Glenmark’s ground-breaking drug discovery effort is primarily focused in the areas of inflammation [asthma/COPD, rheumatoid arthritis etc.], metabolic disorders [diabetes, obesity, etc.] and pain [neuropathic pain and inflammatory pain]. Specialty Business: Formulations Business: Glenmark’s formulations business is currently organized many regions - India, Latin America, Central Eastern Europe and Semi Regulated Markets of Africa/Asia/CIS. The formulations business focuses on therapeutic areas viz. dermatology, anti-infective, respiratory, cardiac, diabetes, gynecology, CNS, and oncology.
personal

Grow your wealth with more research recommendations

+91